A detailed history of Creative Planning transactions in Insmed Inc stock. As of the latest transaction made, Creative Planning holds 44,914 shares of INSM stock, worth $2.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,914
Previous 34,246 31.15%
Holding current value
$2.98 Million
Previous $2.29 Million 42.89%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$62.0 - $79.01 $661,416 - $842,878
10,668 Added 31.15%
44,914 $3.28 Million
Q2 2024

Aug 15, 2024

BUY
$22.0 - $69.71 $293,524 - $930,070
13,342 Added 63.83%
34,246 $2.29 Million
Q1 2024

May 10, 2024

BUY
$25.72 - $29.94 $91,974 - $107,065
3,576 Added 20.64%
20,904 $567,000
Q4 2023

Feb 14, 2024

BUY
$23.42 - $31.74 $93,328 - $126,483
3,985 Added 29.87%
17,328 $536,000
Q3 2023

Nov 16, 2023

BUY
$19.86 - $26.93 $264,991 - $359,326
13,343 New
13,343 $336,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $8.98B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.